Skip to main content
. 2014 Jan 16;209(12):1929–1940. doi: 10.1093/infdis/jiu031

Table 2.

Therapeutic Efficacy of Sm-p80 Using Recombinant Protein and Prime Boost Approaches for Schistosoma mansoni in Baboons

Group, Baboon Individual-Level Findings, Mean ± SE
Group-Level Findings, Mean ± SE
Percentage Reduction From Controla
Sex Age, y Worm Burden, No. Tissue Egg Burden, Eggs/g Fecal Egg Burden, Eggs/g Worm Burden, Worms, No. Tissue Egg Burden, Eggs/g Fecal Egg Burden, Eggs/g Worm Burden Tissue Egg Burden Fecal Egg Burden
GLA-SE control 556.50 ± 72.06 6345.01 ± 679.40 101.11 ± 5.62
 IS84 F 13.41 415 5363.42 ± 1714.28 133.75 ± 12.47
 IN61 F 4.64 727 6163.22 ± 1657.71 92.21 ± 10.22
 BA02 M 9.59 462 8316.97 ± 3677.79 54.95 ± 6.46
 ST32 M 8.70 622 5536.44 ± 2376.92 123.51 ± 10.57
rSm-p80 + GLA-SE 356.00 ± 39.23 2930.70 ± 241.43 67.72 ± 3.57 36.06 53.81 33.02
 ZO00 F 10.99 262 3054.32 ± 326.94 63.42 ± 6.00
 PO96 M 9.79 336 2341.31 ± 837.72 59.77 ± 7.01
 ED59 M 8.90 376 3501.46 ± 1187.86 69.25 ± 8.16
 AN63 F 13.30 450 2825.72 ± 407.90 78.46 ± 7.14
VR1020 + alum control 881.00 ± 2.00 2509.17 ± 585.83 27.32 ± 9.11
 ES45 F 5.60 883 3095.00 ± 1665.00 23.15 ± 9.40
 KI11 M 4.50 879 1923.33 ± 743.33 31.48 ± 17.59
Sm-p80–VR1020 + rSm-p80 + alum 792.50 ± 56.50 2254.04 ± 848.63 23.15 ± 7.94 10.05 10.17 15.25
 TO81 M 4.34 736 3102.67 ± 989.33 10.19 ± 6.07
 FO45 M 4.48 849 1405.42 ± 972.08 36.11 ± 10.52
VR1020 + CpG- ODN control 729.00 ± 64.00 3440.00 ± 1462.31 28.24 ± 7.43
 RA75 M 4.00 665 3893.33 ± 2811.22 27.78 ± 9.75
 CY62 F 4.60 793 2986.67 ± 1193.17 28.70 ± 13.45
Sm-p80–VR1020 + rSm-p80 + CpG-ODN10104 560.00 ± 108.00 1465.00 ± 345.70 24.54 ± 3.61 23.18 57.41 13.11
 ZU03 F 5.90 452 1013.33 ± 421.48 24.07 ± 8.07
 LU04 M 5.40 668 1916.67 ± 516.33 25.00 ± 0.00

Abbreviations: GLA, glucopyranosyl lipid adjuvant; SE, standard error.

a P ≤ .05 for worm burden, ≤.01 for tissue egg burden, and <.0001 for fecal egg burden.